Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04615221

Immunological Mechanisms of Rejection in Uterine Transplantation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Hopital Foch · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the scheduled follow-up of patients. These will be samples whose collection is minimally or not invasive

Detailed description

In the context of uterine transplantation, non-invasive rejection markers will be sought by different approaches, including transcriptomics on a prospective cohort of patients with different types of samples: blood, smear and biopsy. A microbiota study will also be carried out. 3 groups will be studied: 1 group of 10 patients benefiting or having benefited from a uterine transplant, 1 second group made up of their 10 donors, 1 group of 10 control women

Conditions

Interventions

TypeNameDescription
OTHERSpecimensSpecimens (blood, biopsy, cervical smear, vaginal swab)

Timeline

Start date
2020-09-21
Primary completion
2027-09-01
Completion
2033-09-01
First posted
2020-11-04
Last updated
2025-09-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04615221. Inclusion in this directory is not an endorsement.

Immunological Mechanisms of Rejection in Uterine Transplantation (NCT04615221) · Clinical Trials Directory